Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats

Circulation

Volumn 98, Issue 23, 1998, Pages 2621-2628

  Yu, Henry C M ^c   Burrell, Louise M ^a   Black, M Jane ^c   Wu, Leonard L ^c   Dilley, Rodney J ^a,b   Cooper, Mark E ^c   Johnston, Colin I ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c NONE

Author keywords

Collagen; Diet; Growth substances; Hypertension; Sodium

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HEART MUSCLE FIBROSIS; HYPERTENSION; KIDNEY FIBROSIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SALT INTAKE;

EID: 0032497921     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.23.2621     Document Type: Article

References (35)

1. Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, Pingard AM, Shade R, Carey D, Ardaillou R, Paillard F, Chapman J, Thillet J, Michel JB. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med. 1995;1:1009-1016.
2. Antonios TF, MacGregor GA. Salt: more adverse effects. Lancet. 1996; 348:250-251.
3. Messerli FH, Schmieder RE, Weir MR. Salt. A perpetrator of hypertensive target organ disease? Arch Intern Med. 1997;157:2449-2452.
4. Yuan BX, Leenen FH. Dietary sodium intake and left ventricular hypertrophy in normotensive rats. Am J Physiol. 1991;261:H1397-H1401.
5. Frohlich ED, Chien Y, Sesoko S, Pegram BL. Relationship between dietary sodium intake, hemodynamics, and cardiac mass in SHR and WKY rats. Am J Physiol. 1993;264:R30-R34.
6. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Dietary salt intake: a determinant of cardiac involvement in essential hypertension. Circulation. 1988;78:951-956.
7. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res. 1990;67: 1355-1364.
8. Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OH. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation. 1995;91:161-170.
9. Brilla CG, Weber KT. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med. 1992;120:893-901.
10. Johnson RJ, Schreiner GF. Hypothesis:the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension. Kidney Int. 1997;52:1169-1179.
11. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331:1286-1292.
12. Lorrell BH. Transition from hypertrophy to failure. Circulation. 1997;96: 3824-3827.
13. Weber K. Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair. Semin Nephrol. 1997;17:467-491.
14. Johnston CI, Mendelsohn FAO, Casely DJ. Evaluation of renin and angiotensin assays and their clinical applications. Med J Aust. 1971;1: 126-128.
15. Burrell LM, Palmer J, Charlton JA, Thomas T, Baylis PH. A new radioimmunoassay for human atrial natriuretic peptide and its physiological validation. J Immunol. 1990;11:159-175.
16. Young M, Fullerton M, Dilley R, Funder J. Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest. 1994;93:2578-2583.
17. Furuyama M. Histometrical investigation of arteries in reference to arterial hypertension. Tohoku J Exp Med. 1962;76:388-414.
18. Chomczynski P, Cantin M. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
19. Wu LL, Cox A, Roe CJ, Dziadek M, Cooper ME, Gilbert RE. Transforming growth factor-beta one and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. Kidney Int. 1997;51:1553-1567.
20. Floege J, Alpers CE, Burns MW, Pritzl P, Gordon K, Couser WG, Johnson RJ. Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest. 1992;66:485-497.
21. Snedecor GW, Cochran WG. In: Statistical Methods. 8th ed. Ames, Iowa: Iowa State University Press; 1980:228-236.
22. Weber KT, Brilla CG, Campbell SE, Zhou G, Matsubara L, Guarda E. Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure. Blood Press. 1992;1:75-85.
23. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Ishimura Y, Chatani F, Iwao H. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. J Pharmacol Exp Ther. 1995;273:509-515.
24. Thompson NL, Bazoberry F, Speir EH, Casscells W, Ferrans VJ, Flanders KC, Kondaiah P, Geiser AC, Sporn MB. Transforming growth factor beta-1 in acute myocardial infarction in rats. Growth Factors. 1988;1:91-99.
25. Gilbert RE, Cox A, Wu LL, Allen TJ, Hulthen L, Jerums G, Cooper ME. Expression of transforming growth factor-β1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of angiotensin converting enzyme inhibition. Diabetes. 1998;47:414-422.
26. Border WA, Noble NA. TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int. 1997;51:1388-1396.
27. Philips N, Bashey RI, Jimenez SA. Collagen and fibronectin expression in cardiac fibroblasts from hypertensive rats. Cardiovasc Res. 1994;28: 1342-1347.
28. Haller H, Behrend M, Park JK, Schaberg T, Luft FC, Distler A. Monocyte infiltration and c-fms expression in hearts of spontaneously hypertensive rats. Hypertension. 1995;25:132-138.
29. 2+ channel activator evoked by salt-loading in basilar artery of stroke-prone spontaneously hypertensive rats. Life Sci. 1996;59:247-253.
30. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest. 1994;93:2431-2437.
31. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer B. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation. 1993;88:993-1003.
32. Contard F, Glukhova M, Marotte F, Narcisse G, Schatz C, Swynghedauw B, Guez D, Samuel JL, Rappaport L. Diuretic effects on cardiac hypertrophy in the stroke prone spontaneously hypertensive rat. Cardiovasc Res. 1993;27:429-434.
33. Campbell SE, Turek Z, Rakusan K, Kazda S. Cardiac structural remodelling after treatment of spontaneously hypertensive rats with nifedipine or nisoldipine. Cardiovasc Res. 1993;27:1350-1358.
34. Allen TJ, Waldron MJ, Casley D, Jerums G, Cooper ME. Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes. Diabetes. 1997;46:19-24.
35. Kreutz R, Fernandez Alfonso MS, Liu Y, Ganten D, Paul M. Induction of cardiac angiotensin I-converting enzyme with dietary NaCl-loading in genetically hypertensive and normotensive rats. J Mol Med. 1995;73: 243-248.